
A prospective observational study found that age did not independently affect bone mineral density response to romosozumab in postmenopausal women.

Joshua Fitch is the senior editor for Contemporary OB/GYN. He joined the brand in January of 2026, after being the senior editor of our sister publication, Contemporary Pediatrics, since March of 2023. Fitch graduated from Youngstown State University in Youngstown, Ohio, in 2020 with a degree in telecommunications and journalism. He started his career as a news and sports videographer before becoming an on-air sports anchor at the NBC-affiliated news station in Youngstown. Fitch briefly worked as a national content writer for a Chicago-based national television station before joining the Contemporary Pediatrics team. He can be reached at: [email protected].

A prospective observational study found that age did not independently affect bone mineral density response to romosozumab in postmenopausal women.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

A cross-sectional study found that higher body fat percentage and other adiposity measures were inversely associated with endometriosis severity.

The updated Committee Statement reaffirmed the safety and benefits of influenza, COVID-19, Tdap, and RSV vaccines during pregnancy while addressing misinformation and disparities.

Women with endometriosis or adenomyosis face 10- to 11-year diagnostic delays, study finds.

Preeclampsia was associated with an elevated risk of early kidney damage, highlighting gaps in postpartum surveillance.

In this Q&A interview, Marie Anderson, MD, of Columbia University, highlights a study presented at SMFM 2026 linking abortion restriction and increased rates of maternal death in the United States.

The label changes to 6 menopausal HRTs "clarify risk considerations for these drugs," according to a statement from the FDA.

The Society for Maternal-Fetal Medicine has released updated checklists to guide evidence-based management of monochorionic twin pregnancies and reduce preventable complications.

If allowed by prescribers, patients can complete pregnancy tests outside of a medical setting, but must complete pre-treatment pregnancy tests in a medical setting, according to the FDA.

Addressing geographic inequities in maternal-fetal medicine care through workforce investment and policy reform is critical to improving pregnancy outcomes and reducing maternal deaths, according to SMFM.

Women who experienced menopause before age 50 had higher rates of MASLD and adverse metabolic outcomes, according to reasearch published in Diabetes Metabolism Research and Reviews.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

A Chinese study found that menstrual blood HPV testing had a comparable diagnostic accuracy to clinician-collected cervical samples in detecting CIN2+ and CIN3+.

A new ACOG Committee Statement outlines how immigration status affects health outcomes and calls for enforcement-free health care settings.

ACOG continues to support maternal immunization against COVID-19, flu, and RSV amid growing public questions about vaccine safety during pregnancy.

Take a look back at any of our expert video interviews you may have missed from January 2026.

Take a quick look at everything you may have missed in January, from our latest video interviews to new clinical trial data to a FAQ on cervical cancer.

Trial shows higher sensitivity with AI-supported breast cancer screening.

Federal guidance now designates primary hrHPV testing every 5 years as the preferred cervical cancer screening method for most average-risk women aged 30 to 65 years and adds patient self-collection as an acceptable option.

Universal prenatal syphilis screening legislation in Michigan was followed by substantial increases in early third-trimester testing among Medicaid enrollees.

United States labor induction rates have expanded to 37 and 38 weeks despite a lack of randomized evidence supporting non–medically indicated induction before 39 weeks.

The pause request comes as the administration considers whether to keep current federal rules in place that allow for remote access to mifepristone.

A new AHA scientific statement outlines how earlier prevention, rapid diagnosis and timely treatment can reduce the risks of maternal stroke during pregnancy and postpartum.

New national data show major declines in RA mortality among older women, alongside enduring racial and geographic inequities.

Menopause was associated with increased anxiety, depression, sleep problems and reductions in grey matter in key brain regions.

New FDA guidance and AACR-bound data highlight Aviva Bio’s progress in developing a differentiated testosterone therapy aimed at reducing breast cancer risk in women.

The AAP'S 2026 schedule has been endorsed by 12 medical and health organizations, including the American College of Nurse Midwives and the American College of Obstetricians and Gynecologists.

Get caught up with Contemporary OB/GYN! This list helps you navigate our top stories from the week, all in one place.

In patients with diet-controlled gestational diabetes, continuing pregnancy beyond 39 weeks was associated with increasing maternal and neonatal risks.